Literature DB >> 10098864

Metabolic consequences of the cytochrome c oxidase deficiency in brain of copper-deficient Mo(vbr) mice.

W S Kunz1, A V Kuznetsov, J F Clark, I Tracey, C E Elger.   

Abstract

Biochemical micromethods were used for the investigation of changes in mitochondrial oxidative phosphorylation associated with cytochrome c oxidase deficiency in brain cortex from Mo(vbr) (mottled viable brindled) mice, an animal model of Menkes' copper deficiency syndrome. Enzymatic analysis of cortex homogenates from Mo(vbr) mice showed an approximately twofold decrease in cytochrome c oxidase and a 1.4-fold decrease in NADH:cytochrome c reductase activities as compared with controls. Assessment of mitochondrial respiratory function was performed using digitonin-treated homogenates of the cortex, which exhibited the main characteristics of isolated brain mitochondria. Despite the substantial changes in respiratory chain enzyme activities, no significant differences were found in maximal pyruvate or succinate oxidation rates of brain cortex homogenates from Mo(vbr) and control mice. Inhibitor titrations were used to determine flux control coefficients of NADH:CoQ oxidoreductase and cytochrome c oxidase on the rate of mitochondrial respiration. Application of amobarbital to titrate the activity of NADH:CoQ oxidoreductase showed very similar flux control coefficients for control and mutant animals. Alternately, titration of respiration with azide revealed for Mo(vbr) mice significantly sharper inhibition curves than for controls, indicating a more than twofold elevated flux control coefficient of cytochrome c oxidase. Owing to the reserve capacity of respiratory chain enzymes, the reported changes in activities do not seem to affect whole-brain high-energy phosphates, as observed in a previous study using 31P NMR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098864     DOI: 10.1046/j.1471-4159.1999.721580.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease.

Authors:  Stephanie Zlatic; Heather Skye Comstra; Avanti Gokhale; Michael J Petris; Victor Faundez
Journal:  Neurobiol Dis       Date:  2015-01-10       Impact factor: 5.996

2.  Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance.

Authors:  Cecile Vernochet; Arnaud Mourier; Olivier Bezy; Yazmin Macotela; Jeremie Boucher; Matthew J Rardin; Ding An; Kevin Y Lee; Olga R Ilkayeva; Cristina M Zingaretti; Brice Emanuelli; Graham Smyth; Saverio Cinti; Christopher B Newgard; Bradford W Gibson; Nils-Göran Larsson; C Ronald Kahn
Journal:  Cell Metab       Date:  2012-11-15       Impact factor: 27.287

3.  Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.

Authors:  Stephanie A Zlatic; Alysia Vrailas-Mortimer; Avanti Gokhale; Lucas J Carey; Elizabeth Scott; Reid Burch; Morgan M McCall; Samantha Rudin-Rush; John Bowen Davis; Cortnie Hartwig; Erica Werner; Lian Li; Michael Petris; Victor Faundez
Journal:  Cell Syst       Date:  2018-01-31       Impact factor: 10.304

4.  Mitochondrial enzymes in schizophrenia.

Authors:  Parvesh Bubber; Jicheng Tang; Vahram Haroutunian; Hui Xu; Kenneth L Davis; John P Blass; Gary E Gibson
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease.

Authors:  Mark J Niciu; Xin-Ming Ma; Rajaâ El Meskini; Joel S Pachter; Richard E Mains; Betty A Eipper
Journal:  Neurobiol Dis       Date:  2007-05-23       Impact factor: 5.996

6.  6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.

Authors:  Andreas Kupsch; Werner Schmidt; Zemfira Gizatullina; Grazyna Debska-Vielhaber; Jürgen Voges; Frank Striggow; Patricia Panther; Herbert Schwegler; Hans-Jochen Heinze; Stefan Vielhaber; Frank Norbert Gellerich
Journal:  J Neural Transm (Vienna)       Date:  2014-03-14       Impact factor: 3.575

7.  Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease.

Authors:  Jyothi K Mallajosyula; Shankar J Chinta; Subramanian Rajagopalan; David G Nicholls; Julie K Andersen
Journal:  Neurotox Res       Date:  2009-03-05       Impact factor: 3.911

8.  Metabolic control analysis of respiration in human cancer tissue.

Authors:  Tuuli Kaambre; Vladimir Chekulayev; Igor Shevchuk; Kersti Tepp; Natalja Timohhina; Minna Varikmaa; Rafaela Bagur; Aleksandr Klepinin; Tiia Anmann; Andre Koit; Andrus Kaldma; Rita Guzun; Vahur Valvere; Valdur Saks
Journal:  Front Physiol       Date:  2013-06-28       Impact factor: 4.566

9.  In vivo and in vitro assessment of brain bioenergetics in aging rats.

Authors:  Ol'ga Vančová; Ladislav Bačiak; Svatava Kašparová; Jarmila Kucharská; Hector H Palacios; Jaromír Horecký; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2010-11       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.